A carregar...
Cost–utility analysis of 21-gene assay for node-positive early breast cancer
BACKGROUND: For women with lymph node (ln)–positive, estrogen receptor–positive, and her2 (human epidermal growth factor receptor 2)–negative breast cancer (bca), current guidelines recommend treatment with both hormonal therapy and chemotherapy. The 21-gene Recurrence Score (rs) assay might be help...
Na minha lista:
| Publicado no: | Curr Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Multimed Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6821112/ https://ncbi.nlm.nih.gov/pubmed/31708649 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.4769 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|